Scholars Central

Conference abstractPublished 6 Jul 2017

Impact of diuretic therapy on renal outcomes of Chronic Kidney Disease patients

Authors: Yusra Habib Khan, Azmi Sarrif, Azreen Syazril Adnan, Amer Hayat Khan, Tauqeer Hussain Mallhi

University Sains Malaysia, Malaysia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diuretic therapy has been mainstay of treatment in Chronic Kidney Disease (CKD) patients, primarily for hypertension and fluid overload. Apart from their beneficial effects, diuretic use is associated with adverse renal outcomes. Current study aimed to determine outcomes of diuretic therapy. A prospective observational study was conducted by inviting pre-dialysis CKD patients. Fluid overload was assessed by Bioimpedance Analysis (BIA). A total 312 patients (mean age 64.5Ã?±6.43) were enrolled. Among 144 (46.1%) diuretic users, furosemide and hydrochlorothiazide (HCTZ) were prescribed in 69 (48%) and 39 (27%) patients respectively, while 36 (25%) prescribed with combination therapy (furosemide plus HCTZ). Changes in BP, fluid compartments, eGFR decline and progression to RRT were assessed over a follow-up period of 1 year. Maximum BP control was observed with combination therapy (-19.3 mmHg, p<0.001) followed by furosemide (-10.6 mmHg with 80 mg thrice daily (p<0.001)), -9.3 mmHg with 40-60 mg (p<0.001) & -5.9 mmHg with 20-40 mg (p=0.02) while HCTZ offered minimal SBP control (-3.7 mmHg with 12.5-25 mg (p=0.04)). Decline in extracellular water (ECW) ranged from -1.5 L (p=0.01) with thiazide diuretics to -3.8 L (p<0.001) with combination diuretics. Decline in eGFR was maximum (-3.4 ml/min/1.73 m2, p=0.01) with combination diuretics and least with thiazide diuretics (-1.6 ml/min/1.73 m2, p=0.04). Progression to RRT was observed in 36 patients. It is cautiously suggested to discourage the use of diuretic combination therapy and high doses of single diuretic therapy. Prescribing of diuretics should be done by keeping in view benefit versus harm for each patient.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nephrology & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Yusra Habib Khan”
  • BylineArticles whose byline prints “Azmi Sarrif”
  • BylineArticles whose byline prints “Azreen Syazril Adnan”
  • BylineArticles whose byline prints “Amer Hayat Khan”
  • BylineArticles whose byline prints “Tauqeer Hussain Mallhi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels